Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy.

Authors :: Di Cicco M
Del Tufo E
Parolo E
Menconi M
Bernasconi S
Romei C
Di Gangi A
Masini B
Peroni D
Casazza G
Source :: ERJ open research [ERJ Open Res] 2021 Sep 20; Vol. 7 (3). Date of Electronic Publication: 2021 Sep 20 (Print Publication: 2021).
Publication Year :: 2021
Abstract: Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children. https://bit.ly/3BmOYfb.<br />Competing Interests: Conflict of interest: The authors have no conflicts of interest relevant to this article to disclose.<br /> (Copyright ©The authors 2021.)

Full Text Access

Tools